Clinical Trial Update: Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants [Phase 4]

View source ↗

Summary

Phase 4 safety update evaluating fluconazole treatment in premature and full-term newborn infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Fungal Infections
• Patent Ductus Arteriosus

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: Anders Rane, MD, PhD, Senior professor | Conditions: Ductus Arteriosis, Patent, Bacterial Infections and Mycoses | Phase 4 | Status: COMPLETED